×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Arie Belldegrun

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DNAGinkgo Bioworks Holdings, Inc.Arie BelldegrunDirectorJun 12, 2024Option/RSU Exercise-105,263-194,925Jun 14, 2024, 04:26 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorMay 16, 2024Award/Grant$2.90344,8281,000,001539,867May 20, 2024, 09:33 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorMay 16, 2024Buy$2.901,724,1374,999,9971,724,137May 20, 2024, 09:33 PM
URGNUroGen Pharma Ltd.Arie BelldegrunDirectorSep 14, 2022Option/RSU Exercise$5.00160,000800,000408,693Sep 16, 2022, 03:13 PM
URGNUroGen Pharma Ltd.Arie BelldegrunDirectorAug 31, 2022Option/RSU Exercise$5.003,24116,205248,693Sep 02, 2022, 11:40 AM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorJan 12, 2022Buy$12.60155,0391,953,491195,039Jan 14, 2022, 12:02 PM
URGNUroGen Pharma Ltd.Arie BelldegrunDirectorMar 26, 2021Option/RSU Exercise$5.003,24116,205245,452Jun 09, 2021, 01:47 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorMay 24, 2021Option/RSU Exercise$18.22379,0666,906,582583,034May 25, 2021, 08:00 AM
URGNUroGen Pharma Ltd.Arie BelldegrunDirectorMar 24, 2021Option/RSU Exercise$5.003,24116,205245,452Apr 22, 2021, 05:19 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorJun 04, 2020Buy$47.00146,3826,879,9541,798,163Jun 04, 2020, 04:04 PM
URGNUroGen Pharma Ltd.Arie BelldegrunDirectorMar 27, 2019Option/RSU Exercise$4.02128,000514,560212,211Mar 28, 2019, 04:52 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorOct 15, 2018Buy$18.00194,4453,500,0101,691,781Feb 13, 2019, 05:10 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorOct 15, 2018Buy$18.0035,000630,00035,000Oct 17, 2018, 05:29 PM
ALLOAllogene Therapeutics, Inc.Arie BelldegrunDirectorOct 15, 2018Conversion-7,628,936-5,989,352Oct 17, 2018, 05:29 PM